Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-25T18:00:41.858Z Has data issue: false hasContentIssue false
  • English
  • Français

A Clinical Trial of Imipramine (“Tofranil”) on Depressed Patients

Published online by Cambridge University Press:  08 February 2018

W. Ross Ashby  and
G. H. Collins
W. Ross Ashby
Affiliation:
University of Illinois, Urbana, Illinois, U.S.A.
G. H. Collins
Affiliation:
Kingsway Hospital, Derby
Get access Rights & Permissions [Opens in a new window]

Extract

Recently many new anti-depressive drugs have flooded the market, the objective being initially to assist and finally to replace E.C.T. as the treatment of choice for depressive states. One such preparation is Tofranil (N-(γ-Dimethyl-aminopropyl)-iminodibenzyl hydrochloride or imipramine). It was first favourably reported on by Azima (1) and Kuhn (2).

Type
Original Articles
Information
Journal of Mental Science , Volume 107 , Issue 448 , May 1961 , pp. 547 - 551
Copyright
Copyright © Royal College of Psychiatrists, 1961 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Azima, H., and Vispo, R. H., Amer. J. Psychiat., 1958, 115, 245.CrossRefGoogle Scholar
2 Kuhn, R., ibid., 1958, 115, 459.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.